JP3195351B2 - Disposable inhaler - Google Patents
Disposable inhalerInfo
- Publication number
- JP3195351B2 JP3195351B2 JP51531093A JP51531093A JP3195351B2 JP 3195351 B2 JP3195351 B2 JP 3195351B2 JP 51531093 A JP51531093 A JP 51531093A JP 51531093 A JP51531093 A JP 51531093A JP 3195351 B2 JP3195351 B2 JP 3195351B2
- Authority
- JP
- Japan
- Prior art keywords
- powder
- inhaler
- powder chamber
- tape
- inhaler according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
- A61M11/002—Particle size control by flow deviation causing inertial separation of transported particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/14—Static flow deviators in tubes disturbing laminar flow in tubes, e.g. archimedes screws
Abstract
Description
【発明の詳細な説明】 発明の技術分野 本発明は、ほぼ管の形をしており、２つの端を有し、
一端が空気入口を形成しており、他端が空気出口を形成
している種類の呼吸で作動する使い捨て吸入器であっ
て、吸入に適したサイズの粒子を含む吸入しようとする
医薬粉末を収容する吸入器に関する。Description: FIELD OF THE INVENTION The present invention is generally tubular in shape, has two ends,
A respirable disposable inhaler of the type having one end forming an air inlet and the other end forming an air outlet, containing a pharmaceutical powder to be inhaled, comprising particles of a size suitable for inhalation. Related to inhalers.
発明の背景 上記種類の呼吸作動式の使い捨て吸入器は、例えばWO
89/01348、US−Ａ−4,265,236およびEP−Ａ−0404454
に開示されている。BACKGROUND OF THE INVENTION Breath-acting disposable inhalers of the type described above are, for example, WO
89/01348, US-A-4,265,236 and EP-A-0404454
Is disclosed.
EP−Ａ−0404454は、空気入口と空気出口とを備えて
いる医薬粉末を入れるためのチャンバを包含する呼吸作
動式の使い捨て吸入器を開示している。空気の入口と出
口は共通のカバーで覆われている。粉末は前記の比較的
大きなチャンバ内に緩やかに入れてある。このことは、
粉末が必ずしも空気流が最も効率の良い位置にあるとは
限らないということを意味する。EP-A-0 404 454 discloses a breath actuated disposable inhaler comprising a chamber for containing a medicament powder having an air inlet and an air outlet. The air inlet and outlet are covered by a common cover. The powder is loosely placed in the relatively large chamber. This means
This means that the powder is not always in the position where the air flow is most efficient.
US−Ａ−4,265,236は、可撓性のチューブからなり、
このチューブの両端が通常は互いに密封挿入されている
管状の呼吸作動式の使い捨て吸入器を開示している。こ
の種のシールは必ずしも耐湿気性を持っているとは限ら
ない。さらに、チューブの両端を引き離したときに若干
量の粉末が吸入器からこぼれるというリスクもある。US-A-4,265,236 consists of a flexible tube,
Disclosed is a tubular, breath-actuated, disposable inhaler in which the ends of the tube are usually hermetically inserted into each other. This type of seal is not always moisture resistant. In addition, there is a risk that some amount of powder will spill out of the inhaler when the ends of the tube are pulled apart.
WO 89/01348は、ここで最も関心が深い実施態様とし
て、もぎ取りキャップによって両端をシールした管状の
使い捨て吸入器を開示している。医薬粉末は吸入器内に
緩やかに入れてあり、上述した他の吸入器と同様に、吸
入器を開いたときに若干の粉末が失われるというリスク
がある。WO 89/01348 discloses, as the most interesting embodiment here, a tubular disposable inhaler sealed at both ends by a tear-off cap. The medicament powder is loosely placed in the inhaler and, like the other inhalers described above, there is a risk that some powder will be lost when the inhaler is opened.
本発明の目的は、医薬粉末の投与量を正確に決めるこ
とができ、また、医薬粉末を密封保管して湿気から守る
ことのできる上述した種類の使い捨て吸入器を提供する
ことにある。同じ形式の吸入器の別のものから分配され
る投与量はほぼ一定でなければならない。最後に、吸入
器は使用準備が容易であり、使い易いと共に製作が容易
かつ安価でなければならない。It is an object of the present invention to provide a disposable inhaler of the kind described above, which allows the dosage of the medicament powder to be determined accurately and allows the medicament powder to be kept sealed and protected from moisture. The dose dispensed from another of the same type of inhaler should be approximately constant. Finally, the inhaler must be easy to use, easy to use and easy to manufacture and inexpensive.
発明概念の簡単な説明 上記の目的は、使い捨て吸入器が添付の請求の範囲第
１項に記載した特徴を備えているときに達成される。有
利な実施例が請求の範囲の従属項に記載してある。Brief description of the inventive concept The above object is achieved when a disposable inhaler has the features described in the appended claim 1. Advantageous embodiments are described in the dependent claims.
添付図面の簡単な説明 第１図は、本発明による吸入器の斜視図である。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a perspective view of an inhaler according to the present invention.
第２図は、第１図の吸入器の斜視図であるが、吸入器
の２つの主要部分を分解した状態で示す図である。FIG. 2 is a perspective view of the inhaler of FIG. 1, but showing the two main parts of the inhaler in an exploded state.
第3A〜3C図は、第１図の吸入器の粉末室を開く種々の
段階を示す図である。3A to 3C show various stages of opening the powder chamber of the inhaler of FIG.
第４図は、第１図の吸入器の空気入口の端面図であ
る。FIG. 4 is an end view of the air inlet of the inhaler of FIG.
第５〜７図は、粉末室に隣接した絞り部の可能性のあ
る種々の例を示す。5 to 7 show various possible examples of a restriction adjacent the powder chamber.
発明の好ましい実施態様の詳細な説明 本発明の好ましい実施態様が第１〜４図に開示してあ
る。第１図において、吸入器は完全に組み立てた状態で
示してあり、使用準備が整っている。この図からわかる
ように、吸入器は本質的に２つの細長い主要部分からな
る。上部１はプラスチック材料の成形シートからなり、
下部２はプラスチックをラミネートしたアルミフォイル
で作ってあるのが好ましい。上部１はほぼ矩形のＵ字形
である。上部の幅は高さの数倍である。下部はほぼ扁平
であり、これら２つの部分は空気入口４および空気出口
５を備えた空気導管または空気流路を構成する管状のハ
ウジングを形成している。空気入口４に接近して破線で
示す部分球形のくぼみ３がある。このくぼみ３は粉末室
を形成し、テープ６で覆われている。このテープは同様
にプラスチックをラミネートしたアルミフォイルで作ら
れているのが好ましい。くぼみ３は、底に１つまたはい
くつかの小さな貫通孔24を設けてもよい。この貫通孔24
は、下部の下面からくぼみ内へ空気が進入可能なように
充分大きくなければならないが、この孔を通して粉末が
少しでも落下するのを防ぐのに充分小さくなければなら
ない。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS OF THE INVENTION Preferred embodiments of the present invention are disclosed in FIGS. In FIG. 1, the inhaler is shown in a fully assembled state and is ready for use. As can be seen from this figure, the inhaler consists essentially of two elongated main parts. The upper part 1 consists of a molded sheet of plastic material,
The lower part 2 is preferably made of plastic-laminated aluminum foil. The upper part 1 is substantially rectangular U-shaped. The width at the top is several times the height. The lower part is substantially flat, these two parts forming a tubular housing defining an air conduit or air passage with an air inlet 4 and an air outlet 5. Close to the air inlet 4 is a partially spherical depression 3 indicated by broken lines. This recess 3 forms a powder chamber and is covered with tape 6. The tape is preferably also made of plastic-laminated aluminum foil. The depression 3 may be provided with one or several small through holes 24 at the bottom. This through hole 24
Must be large enough to allow air to enter the recess from the lower underside, but small enough to prevent any powder from falling through this hole.
図示したように、くぼみ３を覆っているテープ６の部
分の端はくぼみ３と空気入口４の間に位置している。テ
ープは、第２図でわかるように比較的弱い溶接部22によ
って粉末室のまわりで下部２に取り付けてある。テープ
の端は、空気流の意図した方向で見て粉末室の前方に比
較的大きく、したがって、強い溶接部によって取り付け
てある。テープ６の自由部分はくぼみ３上に折り返され
ており、空気入口４を通して外に延びている。この特別
の実施態様においては、テープの自由部分は上部１から
下方に延びる２つの円錐形の突起７、８によって案内さ
れ、保持される。テープの自由部分は下部２の下面に向
かって輪状に曲げて、比較的弱い溶接部によってくぼみ
３の全周に沿って下部に取り付け、孔24およびくぼみ３
をシールするようにしてもよい。テープは、くぼみ３を
通って延びるに充分に長く、テープを引き剥すためのグ
リップとして作用するタブ25を形成するものでなければ
ならない。As shown, the end of the portion of the tape 6 that covers the depression 3 is located between the depression 3 and the air inlet 4. The tape is attached to the lower part 2 around the powder chamber by a relatively weak weld 22, as can be seen in FIG. The end of the tape is relatively large in front of the powder chamber when viewed in the intended direction of air flow, and is thus attached by a strong weld. The free part of the tape 6 is folded over the recess 3 and extends out through the air inlet 4. In this particular embodiment, the free part of the tape is guided and held by two conical projections 7, 8 extending downward from the upper part 1. The free part of the tape is bent in a loop towards the lower surface of the lower part 2 and attached to the lower part along the entire circumference of the recess 3 by a relatively weak weld, and the hole 24 and the recess 3
May be sealed. The tape must be long enough to extend through the recess 3 and form a tab 25 which acts as a grip for pulling off the tape.
流路の方向に対して直角な向きの隆起９の形をした流
路内の絞り部は粉末室の上方に位置している。この隆起
は上部１におけるくぼみ９として形成されている。隆起
は衝合部10によって各端を定められている。A restriction in the flow channel in the form of a ridge 9 oriented perpendicular to the direction of the flow channel is located above the powder chamber. This ridge is formed as a depression 9 in the upper part 1. The bumps are bounded at each end by abutments 10.
吸入器は、さらに、そこを通る意図した空気流路の方
向で見て粉末室の後にある分解手段を備えている。これ
らの分解手段は吸入器の長手方向に対して約30゜の角度
に向いた多数の斜めの平坦面を包含する。驚くべきこと
には、粉末の凝集塊をばらばらにするための流路方向に
対する平坦面の最も効率の良い角度は約30゜であること
がわかった。空気流が平坦面によって或る程度までそら
されるので、流れ方向は長手方向と完全に一致すること
はないが、上記の角度は最善の妥協角度として選ばれて
いる。しかしながら、この角度は20゜〜50゜の間で変え
ることができ、好ましくは25゜〜35゜の範囲内で変える
ことができる。The inhaler further comprises disintegrating means behind the powder chamber in the direction of the intended air flow path therethrough. These disassembly means include a number of oblique flat surfaces oriented at an angle of about 30 ° to the longitudinal direction of the inhaler. Surprisingly, it has been found that the most efficient angle of the flat surface to the channel direction for breaking up the powder agglomerates is about 30 °. Since the air flow is diverted to some extent by the flat surface, the flow direction does not completely coincide with the longitudinal direction, but the above angle has been chosen as the best compromise angle. However, this angle can vary between 20 ° and 50 °, preferably within the range of 25 ° and 35 °.
平坦面は下部２に対してほぼ直角、すなわち、少なく
とも吸入器を製作する方法で可能な限り直角に向いてい
る。平坦面は、横断面での突起が吸入器の全横断面をほ
ぼ覆うように位置している。これらの突起は、空気流に
捕らえられた任意のより大きい粒子または凝集塊が少な
くとも１つの平坦面に衝突するために、好ましくは或る
程度の範囲でオーバラップしていなければならない。好
ましい実施態様では、これらの平坦面11、12、13、14、
15、16は上部１の側部に形成した２対の凹部17、18;1
9、20の上流端および前記凹部間に位置して流路に島を
形成する中央くぼみ21の上流端に位置する。空気流内に
捕らえられた粉末が凝固する可能性のある領域をなんら
形成することなく良好な空気力学条件を得られるように
するために、前記凹部および前記くぼみの下流端は空気
流の方向に傾斜しており、滑らかな丸くなった形状を持
っている。The flat surface is oriented substantially perpendicular to the lower part 2, ie at least as perpendicular as possible in the way of making the inhaler. The flat surface is located such that the protrusion in the cross section substantially covers the entire cross section of the inhaler. These protrusions should preferably overlap to some extent in order for any larger particles or agglomerates trapped in the air stream to strike at least one flat surface. In a preferred embodiment, these flat surfaces 11, 12, 13, 14,
15 and 16 are two pairs of recesses 17, 18; 1 formed on the side of the upper part 1.
It is located at the upstream end of the central depression 21 which is located between the upstream end of 9, 20 and the recess and forms an island in the flow path. In order to obtain good aerodynamic conditions without forming any regions in which the powder trapped in the airflow may solidify, the downstream ends of the recesses and the depressions are oriented in the direction of the airflow. Inclined, with a smooth, rounded shape.
吸入器の２つの主要部分が第２図に別々に示してあ
る。第１図に示す詳細とは異なり、粉末室３は開いた状
態で示してあり、テープ６は空気入口を通して引き出さ
れている。（破線の）溶接部22の形状はテープ６上と粉
末室３のまわりに示してある。ここでわかるように、溶
接部の形状は吸入器の長手方向寸法と平行な１つの対角
線を持った向きの正方形の外辺部として選ばれている。
このことは、引き裂き作用が角隅で始まり角隅で終るの
で、下部２からのテープの分離が容易になることを意味
している。テープの内端を保持する溶接部が幅広く強い
ので、使用者は抵抗が高まることによって粉末室が開い
たということを感じることになる。The two main parts of the inhaler are shown separately in FIG. Unlike the details shown in FIG. 1, the powder chamber 3 is shown open and the tape 6 has been drawn through the air inlet. The shape of the weld (dashed line) 22 is shown on the tape 6 and around the powder chamber 3. As can be seen, the shape of the weld is chosen as the perimeter of a square with one diagonal parallel to the longitudinal dimension of the inhaler.
This means that the separation of the tape from the lower part 2 is facilitated since the tearing action starts at the corner and ends at the corner. Because the weld holding the inner end of the tape is wide and strong, the user will feel that the powder chamber has opened due to the increased resistance.
第3A〜3C図は、テープ６を引張ることによって粉末室
３を開き、粉末23を露出させる種々の段階を示してい
る。第3A図は、下部の下面にあるくぼみ３のまわりに取
り付けてあり、剥ぎ取りタブ25を残しながら孔２を覆っ
ているテープ６を示している。3A to 3C show the various stages of opening the powder chamber 3 by pulling the tape 6 and exposing the powder 23. FIG. 3A shows the tape 6 mounted around the recess 3 in the lower lower surface and covering the hole 2 leaving the stripping tab 25. FIG.
第４図の端面図は、上部１、下部２、粉末室３、テー
プ６、円錐形突起７、８、隆起９および衝合部10の相互
関係をより明確に示している。The end view of FIG. 4 more clearly shows the interrelation of the upper part 1, the lower part 2, the powder chamber 3, the tape 6, the conical projections 7, 8, the ridges 9 and the abutments 10.
吸入器を使用しようとするときには、吸入器をほぼ水
平方向に保持し、扁平な下部２を下に向ける。テープ６
の自由端をタブ25を使って引張り、孔23と、粉末室３内
の粉末を露出させる。２つの円錐形の突起７、８はテー
プ６を下部２に対して平らに保持し、テープが粉末室前
方にある絞り部を塞ぐのを防ぐ。次に、使用者は口内に
空気出口を挿入し、吸入器を通して吸入する。そうして
生じた空気流は絞り部においてかなりの乱流となり、医
薬粉末は粉末室から持ち上げられ、空気流に混入する。
テープに付着した粒子は、粉末室を最初に覆っているテ
ープの部分が流路内にじかに位置するので、空気流でも
捕らえられ得る。空気をくぼみ３の底に流入させること
によって、貫通孔24は、くぼみからの粉末の持ち上げを
妨げたかもしれないくぼみの底に生じるすべての小圧力
をなくすことになる。When trying to use the inhaler, the inhaler is held in a substantially horizontal direction, with the flat lower part 2 facing down. Tape 6
Is pulled using the tab 25 to expose the hole 23 and the powder in the powder chamber 3. The two conical projections 7, 8 hold the tape 6 flat against the lower part 2 and prevent the tape from blocking the restriction in front of the powder chamber. Next, the user inserts the air outlet into the mouth and inhales through the inhaler. The resulting air flow becomes considerably turbulent in the throttle, and the medicament powder is lifted from the powder chamber and enters the air flow.
Particles adhering to the tape can also be trapped in the air flow, since the portion of the tape that initially covers the powder chamber is located directly in the flow path. By allowing air to flow into the bottom of the cavity 3, the through-holes 24 will eliminate any small pressure created at the bottom of the cavity that may have prevented lifting of the powder from the cavity.
テストでは、約10〜12mm2の面積を有する絞り部に位
置する典型的な粉末室からの投与量（例えば約0.5mg）
は30／分から60／分の空気流量でほぼ一定のままで
あることがわかった。The test dose from a typical powder chamber located in the narrowed portion having an area of about 10-12 mm 2 (e.g., about 0.5 mg)
Was found to remain almost constant at air flow rates of 30 / min to 60 / min.
粉末含有空気は絞り部から分解手段に流れる。斜面の
迎え角により、必然的に軽い方の粒子、すなわち吸入可
能範囲の粒子（＜６μｍ）が表面にくっつくことなく表
面からそれて、主として空気流に追従するのに対し、よ
り重い粒子および凝集塊は平坦面に衝突し、そしてそこ
から跳ね返り、このようにしてより小さい粒子に分解さ
れることになる。上述したように、約30゜の角度が最適
である。The powder-containing air flows from the throttle to the decomposition means. The angle of attack of the slope inevitably causes the lighter particles, ie particles in the inhalable range (<6 μm), to deviate from the surface without sticking to the surface and primarily follow the air flow, whereas heavier particles and agglomerates The clump hits a flat surface and rebounds therefrom, thus breaking up into smaller particles. As mentioned above, an angle of about 30 ° is optimal.
この場合、テストは再び吸入すべき投与量の吸入可能
範囲内の粒子のパーセンテージが30／分から60／分
の空気流量でほぼ一定のままであることを示した。In this case, the tests again showed that the percentage of particles within the inhalable range of the dose to be inhaled remained almost constant at an air flow rate of 30 / min to 60 / min.
広範囲の流量にわたって吸入可能粒子の投与量がほぼ
一定に保たれるということは、異なった吸入能力を持つ
患者の差を最小限に抑えるために重要である。Keeping the dose of inhalable particles nearly constant over a wide range of flow rates is important to minimize differences between patients with different inhalation capacities.
ここで、吸入器が管状形態であると空気入口を覆って
ゴムボールまたは同様のものを装着することが可能にな
るということに注目されたい。こうすると、患者が自分
で吸入器を使用できない場合に介護者により患者の呼吸
に合わせて同時に患者ののどへ吸入器から粉末を放出で
きる。It should be noted here that the tubular form of the inhaler allows a rubber ball or the like to be fitted over the air inlet. This allows the caregiver to release the powder from the inhaler to the patient's throat simultaneously with the patient's breathing if the patient cannot use the inhaler himself.
上述したように、吸入器の下部２ならびにテープ６
は、適当なプラスチックをラミネートあるいはコーティ
ングしたアルミフォイルで作るのが好ましい。アルミは
湿気からの所望の保護を確実にし、プラスチックはテー
プを下部に溶接し、また、下部を上部に溶接するのを確
実にする。下部は、例えば45μの厚さを有するアルミフ
ォイルで作り、このアルミフォイルの片面を25μ厚の延
伸ポリアミドの層で覆い、反対面を60μ厚のポリプロペ
ン層で覆う。上部は、好ましくは300または400μ厚のポ
リプロピペンで作る。投与量が粉末室から放出されたか
どうかを使用者に見えるように上部が透明であってもよ
い。As described above, the lower part 2 of the inhaler and the tape 6
Is preferably made of an aluminum foil laminated or coated with a suitable plastic. Aluminum ensures the desired protection from moisture, and plastic ensures that the tape is welded to the bottom and that the bottom is welded to the top. The lower part is made of, for example, an aluminum foil having a thickness of 45μ, one side of which is covered with a layer of stretched polyamide of 25μ thickness and the other side with a layer of polypropene of 60μ thickness. The upper part is preferably made of 300 or 400μ thick polypropylene propene. The top may be transparent so that the user can see if the dose has been released from the powder chamber.
テープはポリエステル、アルミおよびポリブテンとポ
リプロペンのポリマー混合物からなる層を包含する、
「剥離」効果を有するラミネートで作ってもよい。The tape comprises a layer consisting of polyester, aluminum and a polymer mixture of polybutene and polypropene,
It may be made of a laminate having a "peeling" effect.
吸入器における材料の選択は使用する薬品に適合させ
なければならない。上記の材料は、特殊な薬品（ブデソ
ナイド）を意図して選んだが、これらの材料はこの薬品
の投与量の放出をより容易にするのである。The choice of material in the inhaler must be adapted to the drug used. The above materials were chosen with the intention of a special drug (budesonide), but these materials make it easier to release the dose of this drug.
もちろん、医薬粉末の組成は全く随意であり、粉末は
例えば純粋な活性物質、異なった活性物質の混合物ある
いは活性物質（一種またはそれ以上）と補助剤との混合
物からなることができる。ここで、医薬品の選択範囲は
粉末室内の薬剤の耐湿気性によりかなり広いということ
を指摘したい。Of course, the composition of the pharmaceutical powder is entirely optional and the powder can consist, for example, of the pure active substance, a mixture of different active substances or a mixture of the active substance (s) with adjuvants. Here, it should be pointed out that the selection range of the drug is considerably wide due to the moisture resistance of the drug in the powder chamber.
吸入器は以下の方法によって製作され得る。粉末室を
形成するために一連の半球形のくぼみをラミネート・ア
ルミフォイルのストリップに形成する。これらのくぼみ
に貫通孔を設けるつもりならば、この段階で同時に形成
する。くぼみに医薬品を満たし、クレーパで頂面を均
す。こうすると異なる投与量をほぼ均一にすることにな
る。次に、プラスチックをラミネートしたアルミテープ
を各くぼみを覆って下部のくぼみのまわりに溶接する。The inhaler can be manufactured by the following method. A series of hemispherical depressions are formed in a strip of laminated aluminum foil to form a powder chamber. If these recesses are to be provided with through holes, they are formed simultaneously at this stage. Fill the cavity with the medicine and level the top with a creper. This will make the different doses substantially uniform. Next, a plastic-laminated aluminum tape is welded around the lower cavity, covering each cavity.
次に、下部を上部に溶接し、ストリップを切断して個
々の吸入器を形成する。これらの吸入器は包装および使
用の準備が整っている。上部をプラスチックシートから
成形する。成形作業では、吸入器の全横断面を通してで
きるだけ均一な空気流を得られるようにするために、上
部の側壁面が上面に対してできるだけ直角であるように
注意すべきである。衝合部10の機能は、主として、絞り
部を形成する隆起が溶接作業中にゆがまないようにする
ことにある。Next, the lower part is welded to the upper part and the strip is cut to form individual inhalers. These inhalers are ready for packaging and use. The upper part is molded from a plastic sheet. In the molding operation, care should be taken that the upper side wall surface is as perpendicular as possible to the upper surface in order to obtain as uniform an air flow as possible over the entire cross section of the inhaler. The function of the abutment 10 is primarily to prevent the ridges forming the constriction from being distorted during the welding operation.
発明の可能な変形例 もちろん、本発明は添付の請求の範囲内で多くの方法
で変形可能である。Possible variants of the invention Of course, the invention can be varied in many ways within the scope of the appended claims.
絞り部を形成する隆起９は、粉末に対する空気流の持
ち上げ作用を向上させるために種々の方法で設計でき
る。そのいくつかの例を第５〜７図に示す。The ridge 9 forming the constriction can be designed in various ways to enhance the air flow lifting effect on the powder. Some examples are shown in FIGS.
第５図は、粉末室３の上方中央に隆起９が小さい孔26
を備えることができるのを示している。患者が吸入器を
通して吸入するとき、付加的な空気が粉末室内へほぼ直
角に下向きに送り込まれ、粉末室付近での乱流作用を強
める。FIG. 5 shows a small hole 26 in the upper center of
It is shown that can be provided. As the patient inhales through the inhaler, additional air is pumped down substantially perpendicularly into the powder chamber, enhancing turbulence near the powder chamber.
第６及び７図は２つの別の実施態様を示しており、こ
こでは、隆起はその長手方向に沿って向いた縁27、28を
備えており、また、粉末室内へより直接的に若干量の空
気を送り込むようにもなっている。FIGS. 6 and 7 show two alternative embodiments, in which the ridge has edges 27, 28 oriented along its length, and also a little more directly into the powder chamber. The air is also sent.
しかしながら、これらの実施態様は、所望の効果を得
るには上述した実施態様よりも高度の製作精度を必要と
し、従って製作がより難しい。However, these embodiments require a higher degree of manufacturing accuracy than the embodiments described above to achieve the desired effect, and are therefore more difficult to manufacture.
絞り部を形成する隆起９は、ほぼ台形の横断面とほぼ
直線の縦断面として示したが、添付請求の範囲内で多く
の異なった方法で絞り部を形成できることは了解された
い。Although the ridge 9 forming the constriction has been shown as a substantially trapezoidal cross-section and a substantially straight longitudinal cross-section, it should be understood that the constriction can be formed in many different ways within the scope of the appended claims.
もちろん、粉末室は半球形以外の別の形状であっても
よく、例えば楕円形であり、短軸が空気流の方向と平行
であるようにしてもよいし、あるいは樋状であってもよ
い。また、例えば投与量を正確な方法で増加したい場合
には、いくつかのくぼみを有し得ることももちろんであ
る。上述したように、粉末室は孔24を持たなくてもよ
い。さらに、２つの個別のテープを用いてくぼみ３と孔
24をシールしてもよい。Of course, the powder chamber may be of another shape other than hemispherical, for example elliptical, the minor axis may be parallel to the direction of air flow, or it may be trough-shaped. . It is also possible, of course, to have several depressions, for example if one wishes to increase the dosage in a precise manner. As mentioned above, the powder chamber may not have the holes 24. In addition, the indentation 3 and the hole using two separate tapes
24 may be sealed.
突起７、８は円錐形以外であってもよいし、例えば粉
末室を過ぎてより直接的に空気流のかなりの部分を送る
ように形成してもよい。また、衝合部10と一体であって
もよい。The projections 7, 8 may be other than conical or may be formed, for example, to deliver a significant portion of the airflow more directly past the powder chamber. Further, it may be integrated with the abutment unit 10.
テープ６は、下部２から完全に取り外すように配置し
てもよい。この場合、突起７、８は不要であり、少なく
ともテープを案内し、保持する目的にとっては必要な
い。The tape 6 may be arranged to be completely removed from the lower part 2. In this case, the projections 7, 8 are unnecessary and at least not necessary for the purpose of guiding and holding the tape.
分解手段は、空気流の方向に対して約20゜〜50゜の角
度に向いた平坦面の形以外の形で設計してもよい。この
角度は、もちろん、この範囲外で変化してもよいし、表
面が必ずしも平坦である必要もない。The disintegration means may be designed in a form other than a flat surface oriented at an angle of about 20 ° to 50 ° with respect to the direction of the air flow. This angle may, of course, vary outside of this range, and the surface need not necessarily be flat.
下部およびテープの材料には必ずしもアルミが含まれ
る必要はなく、必要な不透過性および剛性を持つか、あ
るいは、これらの特性を持つように処理した任意のプラ
スチック材料でもよい。The bottom and tape material need not necessarily include aluminum, but may be any plastic material that has the requisite impermeability and rigidity, or has been treated to have these properties.
また、適当な方法で成形した後にロールに巻いたり、
折り畳んだりした単一のシートから吸入器を製作するこ
とも考えられる。Also, after molding by an appropriate method, winding on a roll,
It is also conceivable to make the inhaler from a single folded or sheet.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7，ＤＢ名) A61M 13/00 ──────────────────────────────────────────────────続 き Continued on front page (58) Field surveyed (Int.Cl. 7 , DB name) A61M 13/00
Claims (19)
吸作動式の使い捨て吸入器であって、 空気入口を有するハウジングと、 空気入口と流体連通するする空気出口であって、空気出
口および空気入口の間に延びる空気流路とも流体連通す
る空気出口と、 空気出口および空気入口の間の領域に配置される粉末室
であって、一定投与量の医薬粉末を含み、一定投与量の
医薬粉末を保持するための容量を有し、粉末室の表面を
空気流路に露出させる１つの開口部を備え、さらに周辺
空気が粉末室に進入できるように選択的に開かれる、医
薬粉末の下方に配置された貫通孔とを備えた粉末室と、 医薬粉末を供給する前において、粉末室内の一定投与量
の医薬粉末を保持し、開口部上をシールするように配置
されたテープと、 粉末室に隣接する空気流路に配置された絞り部であっ
て、テープを取り外した後、吸入することにより、粉末
室から医薬粉末を持ち上げ、空気出口を介して供給され
る空気流に医薬粉末を混合させる上で十分な乱流を空気
流内に形成する絞り部とを備えたことを特徴とする吸入
器。1. A breath actuated disposable inhaler for delivering a dose of a pharmaceutical powder, comprising: a housing having an air inlet; an air outlet in fluid communication with the air inlet; An air outlet in fluid communication with an air flow path extending between the air inlets; a powder chamber disposed in an area between the air outlet and the air inlet, wherein the powder chamber contains a fixed dose of pharmaceutical powder; A lower portion of the medicament powder having a capacity to hold the powder, having one opening exposing the surface of the powder chamber to the air flow path, and being selectively opened to allow ambient air to enter the powder chamber; A powder chamber having a through-hole disposed in the powder chamber; and a tape arranged to hold a predetermined dose of the pharmaceutical powder in the powder chamber and seal on the opening before supplying the pharmaceutical powder; The sky adjacent to the room A restrictor arranged in the flow path, which is sufficient for lifting the pharmaceutical powder from the powder chamber by suction after removing the tape and mixing the pharmaceutical powder with the air flow supplied through the air outlet. A throttle for forming a turbulent flow in the air flow.
器。2. The inhaler according to claim 1, wherein the powder chamber has a plurality of through holes.
含む実質的に平坦な下側部分とを有し、 上側部分と下側部分は、長手方向の側面に沿ってシール
するように接合されることを特徴とする吸入器。3. The inhaler according to claim 1, wherein the housing has an upper portion and a substantially flat lower portion including a recess forming a powder chamber, the upper portion and the lower portion. An inhaler wherein the portions are joined so as to seal along a longitudinal side.
を特徴とする吸入器。4. The inhaler according to claim 3, wherein the upper part is formed of a thin plastic sheet.
て、 絞り部は、ハウジングの長手方向の広がりに対して横断
的な方向で、かつ粉末室の上方に配置された凹部として
形成されることを特徴とする吸入器。5. The inhaler according to claim 3, wherein the throttle is formed as a recess arranged in a direction transverse to the longitudinal extent of the housing and above the powder chamber. Inhaler characterized by being performed.
含むラミネートを有することを特徴とする吸入器。6. The inhaler according to claim 3, wherein the lower portion has a laminate including an aluminum foil film and a plastic film.
側へ延びる自由端を有し、粉末室の縁まわりにおいて、
弱い溶接により固定されることを特徴とする吸入器。7. An inhaler according to claim 1, wherein the tape is made of thin foil, has a free end extending outwardly through an air inlet, and around the edge of the powder chamber,
An inhaler characterized by being fixed by weak welding.
末室の間において、下側部分の内側表面に固定され、 テープは、空気入口から粉末室を超えて延びた後、空気
入口を介して外側方向へ延びるように、反対方向に湾曲
することを特徴とする吸入器。8. An inhaler according to claim 7, wherein the inner end of the tape remote from the free end is fixed to the inner surface of the lower part between the air inlet and the powder chamber, An inhaler extending from the air inlet beyond the powder chamber and then curved in the opposite direction so as to extend outwardly through the air inlet.
き出されるとき、弱い溶接部に沿って引き裂かれ易くす
るために、溶接部は、空気流路の下流方向に面した点を
形成することを特徴とする吸入器。9. The inhaler according to claim 8, wherein when the tape is withdrawn from the housing to expose the medicament powder, the weld is air-prone to facilitate tearing along the weak weld. An inhaler characterized by forming a point facing the downstream direction of the flow path.
孔をシールするように配置されることを特徴とする吸入
器。10. The inhaler according to claim 8, wherein the free end of the tape is fixed to the outer surface of the lower part and is arranged to seal the through hole.
分から下方向に延びる突起部をさらに有し、 この突起部は、テープが空気流路を妨げないように、ハ
ウジングの下側部分の方へテープを保持することを特徴
とする吸入器。11. The inhaler according to claim 1, wherein the housing further has a protrusion extending downward from an upper portion between the powder chamber and the air inlet, wherein the protrusion has a tape. An inhaler characterized by holding the tape toward a lower portion of the housing so as not to obstruct the air flow path.
て、分解手段をさらに設けたことを特徴とする吸入器。12. The inhaler according to claim 1, wherein the housing further includes a decomposing means in an air flow path between the powder chamber and the air outlet.
し、 各表面は、ハウジングの長手方向に対して20゜ないし50
゜の角度で傾斜し、ハウジングの長手方向軸を通る平面
に対して実質的に垂直に配置され、 ハウジングの横断面上における平坦な表面の突起部が、
横断面を実質的に覆うことを特徴とする吸入器。13. The inhaler according to claim 12, wherein the disassembling means has a plurality of flat surfaces forming an air flow path, each surface being at least 20 ° to the longitudinal direction of the housing. 50
Inclined at an angle of ゜ and arranged substantially perpendicular to a plane passing through the longitudinal axis of the housing, the projection of the flat surface on the cross section of the housing is:
An inhaler substantially covering a cross section.
入器。14. The inhaler according to claim 13, wherein the angle is 25 ° to 35 °.
器。15. The inhaler according to claim 1, wherein the powder chamber has two through holes.
徴とする吸入器。16. The inhaler according to claim 1, wherein the through hole is arranged at a deepest part of the powder chamber.
ことを特徴とする吸入器。17. The inhaler according to claim 1, wherein the tape is removable from outside the housing.
器。18. The inhaler according to claim 1, wherein the tape has a thin foil.
て、 ハウジングは、上側部分と、粉末室を形成するくぼみを
含む実質的に平坦な下側部分とを有し、 上側部分と下側部分は、長手方向の側面に沿ってシール
するように接合されることを特徴とする吸入器。19. An inhaler according to claim 17 or claim 18, wherein the housing has an upper portion and a substantially flat lower portion including a recess forming a powder chamber, the upper portion comprising: An inhaler characterized in that the lower part is joined so as to seal along the longitudinal side.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP92850046A EP0558879B1 (en) | 1992-03-04 | 1992-03-04 | Disposable inhaler |
| EP92850046.1 | 1992-03-04 | ||
| PCT/EP1993/000473 WO1993017728A1 (en) | 1992-03-04 | 1993-03-03 | Disposable inhaler ii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH07508184A JPH07508184A (en) | 1995-09-14 |
| JP3195351B2 true JP3195351B2 (en) | 2001-08-06 |
Family
ID=8212221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51531093A Expired - Fee Related JP3195351B2 (en) | 1992-03-04 | 1993-03-03 | Disposable inhaler |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5533505A (en) |
| EP (2) | EP0558879B1 (en) |
| JP (1) | JP3195351B2 (en) |
| KR (1) | KR100248522B1 (en) |
| CN (1) | CN1032293C (en) |
| AT (1) | ATE167067T1 (en) |
| AU (1) | AU666171B2 (en) |
| BR (1) | BR9306023A (en) |
| CA (1) | CA2131157A1 (en) |
| CZ (1) | CZ281883B6 (en) |
| DE (1) | DE69319100T2 (en) |
| DK (1) | DK0629136T3 (en) |
| EE (1) | EE03206B1 (en) |
| ES (1) | ES2118223T3 (en) |
| FI (1) | FI111444B (en) |
| GR (1) | GR3027773T3 (en) |
| HU (1) | HU215800B (en) |
| MY (1) | MY116461A (en) |
| NO (1) | NO307596B1 (en) |
| NZ (1) | NZ249128A (en) |
| RU (1) | RU2105573C1 (en) |
| SG (1) | SG49134A1 (en) |
| SK (1) | SK279223B6 (en) |
| UA (1) | UA27056C2 (en) |
| WO (1) | WO1993017728A1 (en) |
| ZA (1) | ZA931520B (en) |
Families Citing this family (122)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY105368A (en) | 1990-03-02 | 1994-09-30 | Glaxo Group Ltd | Inhalation device. |
| SK280967B6 (en) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalation device |
| US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
| US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
| SE9203743D0 (en) | 1992-12-11 | 1992-12-11 | Astra Ab | EFFICIENT USE |
| US6098620A (en) * | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
| US5743250A (en) * | 1993-01-29 | 1998-04-28 | Aradigm Corporation | Insulin delivery enhanced by coached breathing |
| US5873358A (en) * | 1993-01-29 | 1999-02-23 | Aradigm Corporation | Method of maintaining a diabetic patient's blood glucose level in a desired range |
| US5888477A (en) * | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
| US5970973A (en) * | 1993-01-29 | 1999-10-26 | Aradigm Corporation | Method of delivering insulin lispro |
| US5558085A (en) * | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US6131567A (en) * | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
| US5915378A (en) * | 1993-01-29 | 1999-06-29 | Aradigm Corporation | Creating an aerosolized formulation of insulin |
| US5672581A (en) * | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
| US5934272A (en) * | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5819726A (en) * | 1993-01-29 | 1998-10-13 | Aradigm Corporation | Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease |
| US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
| US5724957A (en) * | 1993-01-29 | 1998-03-10 | Aradigm Corporation | Intrapulmonary delivery of narcotics |
| TW360548B (en) * | 1993-04-08 | 1999-06-11 | Powderject Res Ltd | Products for therapeutic use |
| US5497763A (en) * | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| DE4400084C2 (en) * | 1994-01-04 | 2001-08-02 | Softec Gmbh & Co Kg | Device for administering medication in solid form finely distributed in an air stream |
| US5483954A (en) * | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
| US5522385A (en) * | 1994-09-27 | 1996-06-04 | Aradigm Corporation | Dynamic particle size control for aerosolized drug delivery |
| PT805696E (en) * | 1995-01-23 | 2000-08-31 | Direct Haler A S | INHALER |
| US5676643A (en) * | 1995-02-13 | 1997-10-14 | The Procter & Gamble Company | Dispenser for friably releasing dry particulate medicaments |
| SE9502800D0 (en) * | 1995-08-10 | 1995-08-10 | Astra Ab | Disposable inhalers |
| SE9502799D0 (en) * | 1995-08-10 | 1995-08-10 | Astra Ab | Device in inhalers |
| CA2392466C (en) | 1995-12-07 | 2004-05-04 | Jago Research Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
| CN1213974A (en) * | 1996-01-03 | 1999-04-14 | 葛兰素集团有限公司 | Inhalation device |
| USD381416S (en) * | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
| US5699789A (en) * | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
| US6123070A (en) * | 1996-06-07 | 2000-09-26 | Valois S.A. | Device for enhancing the emptying of an inhaler metering chamber |
| SE9700423D0 (en) * | 1997-02-07 | 1997-02-07 | Astra Ab | Disposable inhalers |
| SE9700422D0 (en) * | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler II |
| SE9700421D0 (en) * | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhalation I |
| US5881720A (en) * | 1997-04-29 | 1999-03-16 | The Procter & Gamble Company | Method of delivering halotherapy |
| US6237590B1 (en) | 1997-09-18 | 2001-05-29 | Delsys Pharmaceutical Corporation | Dry powder delivery system apparatus |
| NZ506289A (en) * | 1998-03-16 | 2004-12-24 | Nektar Therapeutics | Aerosolized active agent delivery to the lungs at a flow rate of less than 17 liters per minute |
| SE9800897D0 (en) | 1998-03-17 | 1998-03-17 | Astra Ab | Inhalation device |
| UA73924C2 (en) * | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
| US6070575A (en) | 1998-11-16 | 2000-06-06 | Aradigm Corporation | Aerosol-forming porous membrane with certain pore structure |
| GB9905538D0 (en) * | 1999-03-10 | 1999-05-05 | Glaxo Group Ltd | A device |
| US6223744B1 (en) | 1999-03-16 | 2001-05-01 | Multi-Vet Ltd. | Wearable aerosol delivery apparatus |
| GB9909354D0 (en) | 1999-04-24 | 1999-06-16 | Glaxo Group Ltd | Medicament carrier |
| GB9909357D0 (en) * | 1999-04-24 | 1999-06-16 | Glaxo Group Ltd | Medicament carrier |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| US6606992B1 (en) * | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
| ES2195948T3 (en) * | 1999-10-06 | 2003-12-16 | Eckardt Angela | INHALATION DEVICE FOR DRY POWDER, CONTROLLED BY BREATHING. |
| US6427688B1 (en) | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
| CA2401288A1 (en) | 2000-02-28 | 2001-09-07 | Vectura Limited | Improvements in or relating to the delivery of oral drugs |
| AU2001250901A1 (en) * | 2000-03-27 | 2001-10-08 | Dura Pharmaceuticals, Inc. | Containers for individual doses of an inhalable pharmaceutical |
| AU2001283546A1 (en) | 2000-08-14 | 2002-02-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
| US6443152B1 (en) * | 2001-01-12 | 2002-09-03 | Becton Dickinson And Company | Medicament respiratory delivery device |
| US6644309B2 (en) | 2001-01-12 | 2003-11-11 | Becton, Dickinson And Company | Medicament respiratory delivery device and method |
| US6722364B2 (en) * | 2001-01-12 | 2004-04-20 | Becton, Dickinson And Company | Medicament inhalation delivery devices and methods for using the same |
| US6766799B2 (en) * | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
| US8061006B2 (en) | 2001-07-26 | 2011-11-22 | Powderject Research Limited | Particle cassette, method and kit therefor |
| CN1302824C (en) * | 2001-11-22 | 2007-03-07 | 劳尔·戈尔德曼 | Inhalation device for dry powder controlled by inspiration |
| WO2003080149A2 (en) | 2002-03-20 | 2003-10-02 | Mannkind Corporation | Inhalation apparatus |
| GR1004350B (en) | 2002-03-29 | 2003-09-26 | Inhaler for dry powder | |
| AU2003267809A1 (en) * | 2002-06-07 | 2003-12-22 | Sun Pharmaceutical Industries Limited | Powder inhaler |
| US7185651B2 (en) * | 2002-06-18 | 2007-03-06 | Nektar Therapeutics | Flow regulator for aerosol drug delivery and methods |
| US6941947B2 (en) | 2002-12-18 | 2005-09-13 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
| EP1488819A1 (en) | 2003-06-16 | 2004-12-22 | Rijksuniversiteit te Groningen | Dry powder inhaler and method for pulmonary inhalation of dry powder |
| GB2405798A (en) * | 2003-09-15 | 2005-03-16 | Vectura Ltd | Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device. |
| ES2644717T3 (en) * | 2003-10-21 | 2017-11-30 | Direct-Haler A/S | Inhaler |
| US8147426B2 (en) * | 2003-12-31 | 2012-04-03 | Nipro Diagnostics, Inc. | Integrated diagnostic test system |
| FR2864944B1 (en) * | 2004-01-14 | 2006-03-31 | Valois Sas | STRIP OF BLISTERS FOR INHALER. |
| JP2007522840A (en) * | 2004-02-06 | 2007-08-16 | マイクロドース・テクノロジーズ・インコーポレーテッド | Blister pack used with inhaler |
| US20080090753A1 (en) | 2004-03-12 | 2008-04-17 | Biodel, Inc. | Rapid Acting Injectable Insulin Compositions |
| CN1313184C (en) * | 2004-04-27 | 2007-05-02 | 贺文智 | Film pre-forming two flowing type nozzle, stillpot with the nozzle and technique for producing ultra-fine dust utilizing the stillpot |
| JP5078014B2 (en) | 2004-08-20 | 2012-11-21 | マンカインド コーポレイション | Catalytic reaction of diketopiperazine synthesis. |
| MX2007002189A (en) | 2004-08-23 | 2008-01-11 | Mannkind Corp | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery. |
| US8771257B2 (en) * | 2004-10-15 | 2014-07-08 | Boston Scientific Scimed, Inc. | Drug delivery sheath |
| US20070012316A1 (en) * | 2005-07-14 | 2007-01-18 | Joann Truza | Disposable compact rescue inhaler |
| US7803404B2 (en) | 2005-09-14 | 2010-09-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| GB0520794D0 (en) * | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
| BRPI0620064A2 (en) * | 2005-12-22 | 2011-11-01 | Philip Morris Prod | inhaler device |
| IN2015DN00888A (en) | 2006-02-22 | 2015-07-10 | Mannkind Corp | |
| PT103481B (en) * | 2006-05-16 | 2008-08-01 | Hovione Farmaciencia S A | INHALER OF SIMPLE USE AND INHALATION METHOD |
| EP2043717A1 (en) * | 2006-07-14 | 2009-04-08 | Astra Zeneca AB | Inhalation system and delivery device for the administration of a drug in the form of dry powder |
| JP5196878B2 (en) * | 2006-07-19 | 2013-05-15 | キヤノン株式会社 | Drug delivery device |
| CN101489614A (en) * | 2006-07-19 | 2009-07-22 | 佳能株式会社 | Medicine ejection device |
| WO2008156586A2 (en) * | 2007-06-12 | 2008-12-24 | Alkermes, Inc. | Inhalation device for powdered substances |
| EP2020249A1 (en) | 2007-08-01 | 2009-02-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | Inhalator |
| WO2009046072A1 (en) * | 2007-10-02 | 2009-04-09 | Baxter International Inc | Dry powder inhaler |
| EP2082769B1 (en) * | 2008-01-24 | 2015-06-03 | Vectura Delivery Devices Limited | Inhaler |
| KR101933816B1 (en) | 2008-06-13 | 2019-03-29 | 맨카인드 코포레이션 | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| WO2009155581A1 (en) | 2008-06-20 | 2009-12-23 | Mannkind Corporation | An interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Use of ultrarapid acting insulin |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| US9060927B2 (en) | 2009-03-03 | 2015-06-23 | Biodel Inc. | Insulin formulations for rapid uptake |
| PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
| BRPI1013154B1 (en) | 2009-06-12 | 2020-04-07 | Mannkind Corp | MICROPARTICLES OF DICETOPIPERAZINE WITH SPECIFIC SURFACE AREAS DEFINED, DRY POWDER UNDERSTANDING THE REFERRED MICROPARTICLES, METHOD FOR FORMATION OF THE REFERENCESMICROPARTICLES AND THE FORMATION OF MICROPARTYSTEMS |
| CA2765497A1 (en) * | 2009-07-01 | 2011-01-06 | Astrazeneca Ab | Dispenser and method for entraining powder in an airflow |
| CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| MX359281B (en) | 2010-06-21 | 2018-09-21 | Mannkind Corp | Dry powder drug delivery system and methods. |
| JP2012074674A (en) * | 2010-09-02 | 2012-04-12 | Canon Inc | Semiconductor integrated circuit device |
| MX353285B (en) | 2011-04-01 | 2018-01-05 | Mannkind Corp | Blister package for pharmaceutical cartridges. |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| WO2013036881A2 (en) * | 2011-09-07 | 2013-03-14 | Syphase, Llc | Dry powder inhalation device |
| IN2014DN03093A (en) | 2011-10-24 | 2015-05-15 | Mannkind Corp | |
| SG10201605800UA (en) * | 2012-07-12 | 2016-09-29 | Mannkind Corp | Dry powder drug delivery system and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| KR102499439B1 (en) | 2013-03-15 | 2023-02-13 | 맨카인드 코포레이션 | Microcrystalline diketopiperazine compositions and methods |
| CA2918369C (en) | 2013-07-18 | 2021-06-29 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
| US11491288B2 (en) | 2014-01-08 | 2022-11-08 | Seroton, Inc. | Dispenser for dry-powder inhalation devices |
| US10238820B2 (en) | 2014-01-08 | 2019-03-26 | Seroton, Inc. | Dry-powder inhalation device |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| EP3137140B1 (en) * | 2014-05-02 | 2019-07-10 | Manta Devices, LLC | Delivery device |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| DE102014017409B4 (en) * | 2014-11-26 | 2016-06-09 | Klaus Dieter Beller | Single-dose powder inhaler and process for its preparation |
| EP3316937B1 (en) | 2015-07-02 | 2020-04-08 | Koska Family Limited | Single use delivery device prefilled with a reconstitutable agent |
| AU2017256152B2 (en) | 2016-04-25 | 2022-04-21 | Koska Family Ltd | Medical delivery system |
| WO2018183528A1 (en) | 2017-03-28 | 2018-10-04 | Concentrx Pharmaceuticals, Inc. | Devices and methods for delivering dry powder medicaments |
| WO2018187273A1 (en) * | 2017-04-06 | 2018-10-11 | Mylan Inc. | Low-cost single use powder inhaler |
| KR102639913B1 (en) | 2017-11-17 | 2024-02-23 | 코스카 패밀리 리미티드 | Systems and methods for fluid transfer manifolds |
| USD992110S1 (en) | 2021-08-10 | 2023-07-11 | Koska Family Limited | Sealed fluid container |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US481780A (en) * | 1892-08-30 | Uviversal coupling | ||
| US2549303A (en) * | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
| US4265236A (en) * | 1980-03-31 | 1981-05-05 | Pacella Angelo M | Portable inhalator device |
| GR861995B (en) * | 1985-07-30 | 1986-11-04 | Glaxo Group Ltd | Devices for administering medicaments to patients |
| AT384552B (en) * | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | INHALATION DEVICE FOR DOSING AND DISTRIBUTING SOLID BODIES INTO THE BREATHING AIR |
| CA1329526C (en) * | 1987-08-20 | 1994-05-17 | Hiroshi Ikura | Powdery medicine applicator device |
| US5239991A (en) * | 1989-06-21 | 1993-08-31 | Fisons Plc | Disposable powder medicament inhalation device with peel-off cover |
| GB8914223D0 (en) * | 1989-06-21 | 1989-08-09 | Fisons Plc | Medicament container |
| SE9002895D0 (en) * | 1990-09-12 | 1990-09-12 | Astra Ab | INHALATION DEVICES FOR DISPENSING POWDERS I |
| US5042472A (en) * | 1990-10-15 | 1991-08-27 | Merck & Co., Inc. | Powder inhaler device |
-
1992
- 1992-03-04 EP EP92850046A patent/EP0558879B1/en not_active Expired - Lifetime
-
1993
- 1993-03-03 DE DE69319100T patent/DE69319100T2/en not_active Expired - Fee Related
- 1993-03-03 CA CA002131157A patent/CA2131157A1/en not_active Abandoned
- 1993-03-03 SG SG1996006511A patent/SG49134A1/en unknown
- 1993-03-03 ZA ZA931520A patent/ZA931520B/en unknown
- 1993-03-03 UA UA94095772A patent/UA27056C2/en unknown
- 1993-03-03 HU HU9402541A patent/HU215800B/en not_active IP Right Cessation
- 1993-03-03 US US08/295,709 patent/US5533505A/en not_active Expired - Lifetime
- 1993-03-03 CZ CZ942084A patent/CZ281883B6/en unknown
- 1993-03-03 NZ NZ249128A patent/NZ249128A/en unknown
- 1993-03-03 AT AT93904034T patent/ATE167067T1/en not_active IP Right Cessation
- 1993-03-03 RU RU94040868A patent/RU2105573C1/en not_active IP Right Cessation
- 1993-03-03 KR KR1019940703083A patent/KR100248522B1/en not_active IP Right Cessation
- 1993-03-03 BR BR9306023A patent/BR9306023A/en not_active IP Right Cessation
- 1993-03-03 JP JP51531093A patent/JP3195351B2/en not_active Expired - Fee Related
- 1993-03-03 AU AU34997/93A patent/AU666171B2/en not_active Ceased
- 1993-03-03 DK DK93904034T patent/DK0629136T3/en active
- 1993-03-03 WO PCT/EP1993/000473 patent/WO1993017728A1/en active IP Right Grant
- 1993-03-03 EP EP93904034A patent/EP0629136B1/en not_active Expired - Lifetime
- 1993-03-03 ES ES93904034T patent/ES2118223T3/en not_active Expired - Lifetime
- 1993-03-03 SK SK1049-94A patent/SK279223B6/en unknown
- 1993-03-04 MY MYPI93000386A patent/MY116461A/en unknown
- 1993-03-04 CN CN93103571A patent/CN1032293C/en not_active Expired - Fee Related
-
1994
- 1994-08-30 NO NO943211A patent/NO307596B1/en not_active IP Right Cessation
- 1994-09-02 FI FI944034A patent/FI111444B/en not_active IP Right Cessation
- 1994-11-08 EE EE9400293A patent/EE03206B1/en not_active IP Right Cessation
-
1998
- 1998-08-28 GR GR980401952T patent/GR3027773T3/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3195351B2 (en) | Disposable inhaler | |
| JP2894834B2 (en) | Disposable inhaler | |
| US5568807A (en) | Air-flow control for an inhaler | |
| JP3980653B2 (en) | Drug single dose aspirator II | |
| MXPA01012789A (en) | Systems and methods for aerosolizing pharmaceutical formulations. | |
| JPH0337077A (en) | Throw-away medicene inhaler | |
| US7465287B2 (en) | Apparatus for dispensing powdered material | |
| RU2760856C2 (en) | Disposable inhaler for powdered medicines | |
| JP5394440B2 (en) | Inhaler | |
| US11577033B2 (en) | Valved spacer for inhalation device | |
| IE920760A1 (en) | Disposable inhaler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080601 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090601 Year of fee payment: 8 |
|
| LAPS | Cancellation because of no payment of annual fees |